Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Zynex ( (ZYXIQ) ) has provided an announcement.
On December 15, 2025, Zynex, Inc. and certain subsidiaries filed voluntary Chapter 11 petitions in the U.S. Bankruptcy Court for the Southern District of Texas, initiating a court-supervised restructuring process. The proceedings are being jointly administered under the case caption In re Zynex, Inc., et al., Case No. 25-90810, and have involved multiple iterations of a combined disclosure statement and reorganization plan.
Between January 14 and February 7, 2026, the company filed successive amended versions of its combined disclosure statement and joint plan of reorganization, culminating in a Third Amended Plan that incorporated a global settlement among Zynex, an ad hoc noteholder group, and the official committee of unsecured creditors. On February 9, 2026, Zynex began soliciting votes on this plan, with a voting deadline set for March 12, 2026, and the plan contemplates an equity transaction with a plan sponsor selected through a parallel sale process.
The latest plan revisions adjust the scope of general unsecured creditor trust claims, causes of action, and released parties, as well as add further tax-related disclosures, potentially affecting recoveries for different creditor classes. The company cautioned that trading in its securities during the Chapter 11 process is highly speculative, warning that market prices may not reflect ultimate recoveries and that existing equity holders are expected to suffer significant losses if the restructuring transactions proceed as outlined.
The most recent analyst rating on (ZYXIQ) stock is a Hold with a $0.05 price target. To see the full list of analyst forecasts on Zynex stock, see the ZYXIQ Stock Forecast page.
Spark’s Take on ZYXIQ Stock
According to Spark, TipRanks’ AI Analyst, ZYXIQ is a Underperform.
The score is driven primarily by distressed financial performance (declining revenue, losses, negative equity/leverage risk) and strongly bearish technicals (price far below moving averages and negative MACD). Valuation is not meaningfully supportive due to negative earnings and no dividend, while the earnings call outlines remediation efforts but confirms significant ongoing financial strain.
To see Spark’s full report on ZYXIQ stock, click here.
More about Zynex
Zynex, Inc. operates in the medical technology sector, providing healthcare-related products and services through its subsidiaries. The company’s capital structure involves various noteholders and unsecured creditors, reflecting a leveraged profile that has made it sensitive to shifts in financing conditions and creditor negotiations.
Average Trading Volume: 6,239,632
Technical Sentiment Signal: Sell
Current Market Cap: $942K
Learn more about ZYXIQ stock on TipRanks’ Stock Analysis page.